Press release
Fibrotic Diseases Treatment Market Top Companies Study - AbbVie Inc., Gilead Sciences, Inc., KITHER BIOTECH S.R.L., BioMX.
Fibrotic Diseases Treatment Market
According to the latest research by InsightAce Analytic, the Fibrotic Diseases Treatment Market is valued at US$ 3.57 billion in 2023, and it is expected to reach US$ 5.40 billion by 2031, with a CAGR of 5.53% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2876
Fibrosis is characterized by the accumulation of fibrous connective tissue resulting from injury, tissue damage, or pathological conditions. This process, which may occur as part of the natural wound healing mechanism or due to chronic disorders, often leads to the excessive formation of scar tissue in organs such as the skin, liver, kidneys, and lungs. The global market for fibrosis treatment is poised for growth, primarily driven by the increasing incidence of fibrotic diseases and a rising global prevalence of risk factors, including smoking.
Moreover, continuous advancements in therapeutic technologies and increasing healthcare expenditures across both developed and emerging economies are expected to enhance the capacity of manufacturers to develop and commercialize innovative treatment solutions. These trends are anticipated to create favorable conditions for market expansion and competitive differentiation in the coming years.
List of Prominent Players in the Fibrotic Diseases Treatment Market:
• AbbVie Inc.
• Gilead Sciences, Inc.
• KITHER BIOTECH S.R.L.
• BioMX
• Verona Pharma plc
• Genentech, Inc.
• C.H. Boehringer Ingelheim International GmbH
• Redx Pharma Plc
• Alpine Immune Sciences
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Camber Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• BellBrook Labs
• Enveda
• Intercept Pharmaceuticals, Inc.
• Pharmaxis Ltd
• Accord Healthcare
• Other Market Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The rising global prevalence of fibrotic disorders, particularly those associated with aging and obesity, is becoming a significant public health and socioeconomic concern. This trend is a key driver in the growth of the fibrotic disease treatment market. For instance, the increasing incidence of idiopathic pulmonary fibrosis (IPF) has significantly elevated the demand for therapeutic agents such as nintedanib and pirfenidone. Moreover, the widespread prevalence of cigarette smoking continues to exacerbate fibrotic conditions, particularly IPF, as tobacco smoke contains reactive oxygen and nitrogen species that contribute to inflammation and tissue fibrosis. These developments emphasize the urgent need for innovative therapeutic approaches, including interventions aimed at smoking cessation, thereby further stimulating market growth.
Challenges:
The high cost of treatment remains a critical barrier to market growth, fueled by both the rising incidence of fibrotic diseases and the increasing prices of prescription medications and medical technologies. Although technological advancements have enhanced treatment precision and outcomes, they have also contributed to elevated healthcare expenditures. This financial burden may limit access to care, particularly for cost-sensitive patient populations. Furthermore, in developing regions, the diagnosis and management of conditions such as IPF are constrained by limited access to essential diagnostic tools, including lung function testing and imaging technologies. The absence of reliable biomarkers and the inadequate availability of healthcare infrastructure in remote areas further impede timely diagnosis and treatment, restricting market growth in these regions.
Regional Trends:
North America is projected to maintain a leading position in the fibrotic disease treatment market, primarily due to its aging population and the high prevalence of fibrotic disorders. The region also benefits from the strong presence of prominent pharmaceutical and biotechnology companies, which fosters innovation and accelerates the development of advanced therapies. In contrast, the Asia-Pacific region is expected to witness substantial growth, driven by rapid advancements in medical technology, improving healthcare infrastructure, and increasing efforts to address unmet clinical needs. These factors are enhancing access to effective treatment options and are expected to significantly boost the region's contribution to the global fibrotic disease treatment market.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2876
Recent Developments:
• In Oct 2022, AbbVie declared the acquisition of D.J.S. Antibodies Ltd. D.J.S.'s primary program is DJS-002, a prospective first-in-class lysophosphatidic acid (L.P.A.) receptor 1 (LPAR1) antagonist antibody now undergoing experimental preclinical research for the treatment of Idiopathic Pulmonary Fibrosis (I.P.F.) and other fibrotic disorders. Idiopathic pulmonary fibrosis (I.P.F.) is a severe, high-mortality condition characterized by fibrotic lung scarring and continues to represent a significant unmet medical need.
Segmentation of Fibrotic Diseases Treatment Market-
By Treatment-
• Medication
• Organ Transplantation
• Oxygen Therapy
• Others
By Application-
• Idiopathic Pulmonary Fibrosis
• Hepatic Cirrhosis
• Renal Fibrosis
• Cutaneous Fibrosis
• Others
By End User-
• Hospitals
• Specialty Clinics
• Academic and Research Institutes
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/fibrotic-diseases-treatment-market/2876
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibrotic Diseases Treatment Market Top Companies Study - AbbVie Inc., Gilead Sciences, Inc., KITHER BIOTECH S.R.L., BioMX. here
News-ID: 4072180 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Activated Carbon Fiber market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Activated Carbon Fiber Market Size, Share & Trends Analysis Report By Type (PAN-based, Pitch-based, Cellulosic Fiber, Phenolic Resin), Application (Solvent Recovery, Air Purification, Water Treatment, Catalyst Carrier)- Market Outlook And Industry Analysis 2031"
The global activated carbon fiber market is estimated to reach over USD 500.04 million by 2031, exhibiting a CAGR of 7.81%…
Heparin-Induced Thrombocytopenia (HIT) Treatment Market Key Players Analysis - P …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Heparin-Induced Thrombocytopenia (HIT) Treatment Market - (By Drug Types (Lepirudin, Danaparoid, Argatroban), By Test Types (Enzyme Immunoassay (EIA), Serotonin Release Assay (SRA), Enzyme-Linked Immunosorbent Assay (ELISA), Heparin-Induced Platelet Activation (HIPA) Test), By End User (Hospitals, Diagnostic Centers, Specialized Clinics, Hospital Pharmacy, Home Care Setting, Mail Order Pharmacy)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Acquired Orphan Blood Disease Market Exclusive Trends Analysis with Forecast to …
According to a new report by InsightAce Analytic, "Global Acquired Orphan Blood Disease Market Size is valued at USD 9.4 Billion in 2024 and is predicted to reach USD 26.1 Billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034.
Report For Free Sample Pages @
https://www.insightaceanalytic.com/request-sample/1456
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Acquired Orphan Blood Disease Market are:
• Increased Research And…
Mitochondrial-Based Therapeutics Market Expected to Grow at 7.5 Percent CAGR as …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Mitochondrial-Based Therapeutics Market - (By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication (Mitochondrial Myopathy, Leber's heredity Optic Neuropathy, Leigh Syndrome, Mitochondrial DNA Depletion Syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis, Myoclonic Epilepsy with ragged red Fibres), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies)), Trends,…
More Releases for Treatment
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of…
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking…
